Sign In

Shilpa Sambashivan

Vice President, Biology at Nura Bio Inc.

Shilpa Sambashivan is the Chief Executive Officer and a member of the Board of Directors at Nura Bio, a clinical-stage biopharmaceutical company that develops neuroprotective therapies.129 Nura Bio focuses on creating therapies that prevent axon degeneration and modulate microglial responses to injury, with the goal of conferring neuroprotection across diseases of the central, peripheral, and ocular nervous systems.26 The company's research is centered around preventing neuronal loss and restoring the function of the neuron-glia axis to improve the nervous system’s immune surveillance capacity in response to neurological injury.478

Sambashivan has been with Nura Bio since April 2018 and was a member of the founding scientific team.35 Before becoming CEO, she served as the company's Chief Scientific Officer and led the establishment of Nura Bio’s R&D engine and small molecule pipeline.15 Prior to joining Nura Bio, Sambashivan spent nearly a decade at Amgen and NGM Biopharmaceuticals, where she defined R&D strategy and led drug discovery programs.1

Sambashivan holds an undergraduate degree in Biological Sciences from the Birla Institute of Science and Technology in India.1 She earned a graduate degree in Molecular Biology and Protein Biochemistry from UCLA, where she researched protein misfolding in neurodegenerative diseases.1 She was also a Bio-X Genentech Foundation postdoctoral fellow at Stanford University.1

Highlights

Feb 18 · businesswire.com
Nura Bio Expands Leadership Team with C-Suite Appointments
Feb 13 · nurabio.com
SHILPA SAMBASHIVAN, PhD | Nura Bio™
Nov 11 · theorg.com
Shilpa Sambashivan - Chief Executive Officer at Nura Bio | The Org
Sep 18 · leadiq.com
Nura Bio Company Overview, Contact Details & Competitors | LeadIQ
Sep 17 · nurabio.com
Nura Bio Closes Series A Financing with $68 Million in New Funds ...
Sep 17 · nurabio.com
Nura Bio Launches to Discover and Develop Neuroprotective Drugs ...
Sep 17 · businesswire.com
Nura Bio Closes Series A Financing with $68 Million in New Funds ...
Nura Bio Closes Series A Financing with $68 Million in New Funds ...
Nura Bio Inc. - The Transatlantic Life Sciences Web Portal

Related Questions

What are Shilpa Sambashivan's main responsibilities as CEO of Nura Bio?
How did Shilpa Sambashivan's experience at Amgen and NGM Biopharmaceuticals influence her career at Nura Bio?
What are the key neuroprotective therapies being developed by Nura Bio?
How did Shilpa Sambashivan's postdoctoral research at Stanford University impact her career?
What is the significance of Nura Bio's $68 million Series A financing?
Shilpa Sambashivan
Shilpa Sambashivan, photo 1
Shilpa Sambashivan, photo 2
Add to my network

Location

South San Francisco, California